Literature DB >> 3440101

Theophylline and antipyrine disposition in smoking and non-smoking epileptic subjects.

D W Acheson1, S Uden, J M Braganza, S W Brown, J B Houston.   

Abstract

Theophylline and antipyrine disposition has been compared in smoking epileptic patients, non-smoking epileptic patients and non-smoking healthy volunteers. Although clear differences in drug clearance and half-life were evident as a result of anticonvulsant drug therapy, no effect of smoking was discernible. Thus, additive effects from induction of the hepatic microsomal monooxygenase system in man by anticonvulsant drugs and polycyclic aromatic hydrocarbons (in cigarette smoke) were not evident.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3440101      PMCID: PMC1386408          DOI: 10.1111/j.1365-2125.1987.tb03250.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking.

Authors:  R E Vestal; A H Norris; J D Tobin; B H Cohen; N W Shock; R Andres
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

Review 2.  Multiplicity of mammalian microsomal cytochromes P-45.

Authors:  A Y Lu; S B West
Journal:  Pharmacol Rev       Date:  1979-12       Impact factor: 25.468

3.  Induction of drug metabolism. II. Qualitative differences in the microsomal N-demethylating systems stimulated by polycyclic hydrocarbons and by phenobarbital.

Authors:  N E Sladek; G J Mannering
Journal:  Mol Pharmacol       Date:  1969-03       Impact factor: 4.436

4.  The P450 gene superfamily: recommended nomenclature.

Authors:  D W Nebert; M Adesnik; M J Coon; R W Estabrook; F J Gonzalez; F P Guengerich; I C Gunsalus; E F Johnson; B Kemper; W Levin
Journal:  DNA       Date:  1987-02

Review 5.  Clinical implications of enzyme induction and enzyme inhibition.

Authors:  B K Park; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

6.  Differential effects of cimetidine on theophylline metabolic pathways.

Authors:  J J Grygiel; J O Miners; R Drew; D J Birkett
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Phenytoin-theophylline interaction.

Authors:  J F Marquis; S G Carruthers; J D Spence; Y S Brownstone; J H Toogood
Journal:  N Engl J Med       Date:  1982-11-04       Impact factor: 91.245

8.  A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.

Authors:  E Perucca; A Hedges; K A Makki; M Ruprah; J F Wilson; A Richens
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

Review 9.  Pharmacokinetic drug interactions with theophylline.

Authors:  J H Jonkman; R A Upton
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

10.  Cigarette smoking and theophylline clearance and metabolism.

Authors:  J J Grygiel; D J Birkett
Journal:  Clin Pharmacol Ther       Date:  1981-10       Impact factor: 6.875

View more
  1 in total

1.  Toward an animal model of chronic pancreatitis. Pancreatobiliary secretion in hamsters on long-term treatment with chemical inducers of cytochromes P450.

Authors:  S C Rutishauser; A E Ali; I J Jeffrey; L P Hunt; J M Braganza
Journal:  Int J Pancreatol       Date:  1995-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.